[
  {
    "type": "DIAGNOSIS",
    "subType": "ICD_10",
    "code": "A049",
    "desc": "Bacterial intestinal infection, unspecified",
    "formattedCode": "A04.9"
  },
  {
    "type": "DRUG",
    "subType": "NDC",
    "code": "0002-1243",
    "desc": "MOUNJARO (tirzepatide)",
    "fullDesc": "MOUNJARO (tirzepatide); Form: Injection, solution; Route: Subcutaneous; Labeler: Eli Lilly and Company",
    "startDate": "2023-07-28",
    "endDate": "2024-12-31"
  },
  {
    "type": "PROCEDURE",
    "subType": "CPT",
    "code": "0001A",
    "desc": "Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; first dose",
    "fullDesc": "Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; first dose",
    "shortDesc": "ADM SARSCOV2 30MCG/0.3ML 1ST",
    "startDate": "2020-12-11",
    "endDate": "2023-10-31"
  }
]